| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $51.46M | - | |
| Other | 401.3K | $9.47M | -5,000 | |
| CFO | 256.7K | $6.06M | - | |
| Other | 230.7K | $5.44M | -105,762 | |
| Other | 113.5K | $2.68M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 1,698 | $9.00 | $15,282.00 | -0.1% | +21.9% | +60.5% | |
| Mar 13, 2025 | Griffin Michelle Renee80 | Director | Sell | 36,291 | $7.19 | $260,932.29 | -70.2% | +48.3% | +83.7% | |
| Mar 12, 2025 | Hershberg Robert64 | Director | Sell | 53,000 | $7.59 | $402,270.00 | -43.2% | +37.3% | +63.4% | |
| Mar 10, 2025 | Neupert Peter M | Director | Sale+OE | 10,000 | $7.05 | $70,500.00 | -4.3% | +56.7% | +117.7% | |
| Mar 6, 2025 | Griffin Michelle Renee80 | Director | Sell | 15,664 | $7.94 | $124,372.16 | -23.3% | +28.4% | +91.2% | |
| Mar 6, 2025 | Robins Chad M62 | CEO And Chairman | Sell | 219,569 | $7.29 | $1,600,416.95 | -2.5% | +28.4% | +91.2% | |
| Mar 5, 2025 | Benzeno Sharon78 | Chief Commercial Ofc Imm Med | Sell | 44,665 | $6.98 | $311,792.35 | -5.4% | +23.8% | +98.3% | |
| Mar 5, 2025 | Piskel Kyle | Chief Financial Officer | Sell | 10,320 | $6.98 | $72,072.21 | -1.2% | +23.8% | +98.3% | |
| Mar 5, 2025 | Rubinstein Julie78 | President And COO | Sell | 59,505 | $6.98 | $415,539.51 | -4.7% | +23.8% | +98.3% | |
| Mar 5, 2025 | Robins Harlan S83 | Chief Scientific Officer | Sell | 96,656 | $6.99 | $675,219.41 | -3.6% | +23.8% | +98.3% |